Care and cost consequences of pediatric whole genome sequencing compared to chromosome microarray

Robin Z Hayeems1,2, Jasmin Bhawra3, Kate Tsiplova4

  • 1Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, Canada. robin.hayeems@sickkids.ca.

Insights

Whole-genome sequencing (WGS) in children with developmental delay prompts more specialist visits than chromosome microarray (CMA), but fewer lab tests. Downstream care costs are generally low, guiding tailored treatments.

Area of Science:

  • Genomics
  • Pediatric Medicine
  • Healthcare Economics

Background:

  • Whole-genome sequencing (WGS) is increasingly used in pediatrics.
  • Its impact on healthcare activities and costs compared to chromosome microarray (CMA) needs evaluation.
  • Understanding downstream care is crucial for optimal genomic testing implementation.

Purpose of the Study:

  • To compare healthcare activities and costs following pediatric WGS versus CMA in children with developmental delay.
  • To analyze how WGS results (diagnostic vs. non-diagnostic) influence downstream care.
  • To assess the economic implications of WGS in complex pediatric cases.

Main Methods:

  • Prospective study of 101 children with developmental delay over one year.
  • Ascertainment and costing of healthcare activities prompted by WGS and CMA.
  • Comparative analysis of activities and costs between WGS and CMA, considering WGS result status.

Main Results:

  • Ongoing care constituted the majority (88.6%) of post-test activities.
  • CMA prompted more laboratory tests (0.55 vs. 0.09; p=0.007), while WGS prompted more specialist visits (0.41 vs. 0; p=0.016).
  • WGS results significantly modified the number of activities (p<0.001); diagnostic WGS led to tailored care, while CMA prompted further investigations.

Conclusions:

  • WGS in pediatric care shifts focus from broad investigations to targeted management based on genotypic findings.
  • Downstream healthcare activity costs prompted by WGS are typically low for most patients.
  • Effective integration of WGS requires careful evaluation of its downstream care and cost consequences.

Related Concept Videos

Next-generation Sequencing03:00

Next-generation Sequencing

The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
99.2K
DNA Microarrays02:34

DNA Microarrays

Microarrays are high-throughput and relatively inexpensive assays that can be automated to analyze large quantities of data at a time. They are used in genome-wide studies to compare gene or protein expression under two varied conditions, such as healthy and diseased states. Microarrays consist of glass or silica slides on which probe molecules are covalently attached through surface functionalization. Most commonly, the slides are prepared through the chemisorption of silanes to silica...
21.4K
Genomics02:02

Genomics

Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
41.0K
Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
18.8K